Biochemistry AI

Nicolas Tilmans is the cofounder and CEO of Anagenex, an AI-powered drug discovery platform. They have raised $37M in funding so far from investors such as Lux Capital, Khosla Ventures, Air Street, Menlo, and Catalio. He was previously the VP of Engineering at Lumiata. He has a PhD in Biochemistry from Stanford. In this episode, we cover a range of topics including: - What are small molecule drugs and why are they challenging to develop - The founding of Anagenex - Data generation engine - DN...